Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. This evidence concerns the gene SSTR2 and digestive system neuroendocrine tumor, grade 1/2.